A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

Frailty strongly predicts worse RSV outcomes in older adults, highlighting the need for targeted care as aging populations ...

The global respiratory syncytial virus respiratory syncytial virus treatment market is undergoing rapid growth, driven by ...

Winter is here, along with cold days and the inevitable seasonal surge in respiratory viruses. But it's not only the sniffles ...

A newly approved shot could soon help protect babies from respiratory syncytial virus, the top cause of hospitalization in US infants.

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

Approval of Enflonsia was based on data from the Phase IIb/III CLEVER trial, which showed a 60.5% reduction in medically ...

Dr. Fiona Havers, who studied medicine at the University of Washington, says the wholesale dismissal of the CDC's scientific ...

Here’s what causes colds to spread so easily, how long they are usually contagious and how they’re most commonly treated.

MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.

Cleveland health officials are warning residents after a 250% spike in COVID-19 viral levels was found in city wastewater.